$221.38
Price
$7.0B
Market Cap
—
P/E Ratio
-30.7
Forward P/E
$-11.20
EPS (TTM)
—
Dividend Yield
$420M
Cash
$4M
Total Debt
31M
Shares Out
$15.22
$221.42
52-Week Range
Institutional Ownership of CIDARA THERAPEUTICS INC
|
Fund / Manager
Click to search
|
Shares | Value | % of Portfolio | Cost Basis | Est. Return |
|---|---|---|---|---|---|
| No funds currently hold this stock. | |||||
Trading Activity for CIDARA THERAPEUTICS INC
|
Fund / Manager
Click to search
|
Action | Change | Shares After | Value | Price |
|---|---|---|---|---|---|
| No activity found for this stock. | |||||
Insider Trading for CIDARA THERAPEUTICS INC
6 Months Insider Sentiment
Buy $0
Sell $2.2M
0
Buys
2
Sells
-2.2M
Net
5
Grants
Largest
$2.2M
Ward
$130K
Ward
$58K
Ward
| Date |
Insider
Click to search
|
Role
Click to search
|
Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jan 07, 2026 | RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | EXERCISE | 1.29M | $0.00 | $129 |
| Dec 29, 2025 | Nicole Negar Davarpanah | Chief Medical Officer | GRANT | 450 | — | — |
| Dec 22, 2025 | Jeffrey Stein | President & CEO | GRANT | 5.4K | — | — |
| Dec 19, 2025 | Jeffrey Stein | President & CEO | GRANT | 10.6K | — | — |
| Dec 17, 2025 | Jeffrey Stein | President & CEO | GRANT | 2.2K | — | — |
| Dec 10, 2025 | Shane Ward | COO & CLO | SELL | 10.0K | $220.08 | $2.2M |
| Dec 10, 2025 | Jeffrey Stein | President & CEO | GRANT | 33.1K | — | — |
| Dec 10, 2025 | Shane Ward | COO & CLO | EXERCISE | 3.5K | $16.65 | $58K |
| Dec 10, 2025 | Shane Ward | COO & CLO | EXERCISE | 6.5K | $20.20 | $130K |
| Sep 11, 2025 | Nicole Negar Davarpanah | Chief Medical Officer | SELL | 474 | $62.86 | $30K |